FLAVIN JOHN L
SEC CIK 1126556 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Dir | 413.0K | — | — | 4 | 2021-10-13 | 2024-03-26 |
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
FLAVIN JOHN L made no open-market trades at PYXS in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-28 | 2024-03-26 | PYXS | Pyxis Oncology, Inc. | FLAVIN JOHN L | Dir | A - Grant | $0.00 | +35.2K | 413.0K | +9% | $0 | |
| 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | FLAVIN JOHN L | Dir | A - Grant | $0.00 | +139.4K | 377.8K | +58% | $0 | |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | FLAVIN JOHN L | Dir | A - Grant | $0.00 | +66.8K | 238.4K | +39% | $0 | |
| D | 2021-10-15 | 2021-10-13 | PYXS | Pyxis Oncology, Inc. | FLAVIN JOHN L | Dir | C - Cnv Deriv | — | +2,388 | 171.6K | +1% | — |
Purchase Sale Sale after option exercise All abbreviations